Cargando…

Polygenic signal for symptom dimensions and cognitive performance in patients with chronic schizophrenia

Genetic etiology of psychopathology symptoms and cognitive performance in schizophrenia is supported by candidate gene and polygenic risk score (PRS) association studies. Such associations are reported to be dependent on several factors - sample characteristics, illness phase, illness severity etc....

Descripción completa

Detalles Bibliográficos
Autores principales:	Xavier, Rose Mary, Dungan, Jennifer R., Keefe, Richard S.E., Vorderstrasse, Allison
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852279/ https://www.ncbi.nlm.nih.gov/pubmed/29552508 http://dx.doi.org/10.1016/j.scog.2018.01.001

Ejemplares similares

Associations Between Schizophrenia Polygenic Liability, Symptom Dimensions, and Cognitive Ability in Schizophrenia
por: Legge, Sophie E., et al.
Publicado: (2021)

Relationship between polygenic risk scores and symptom dimensions of schizophrenia and schizotypy in multiplex families with schizophrenia
por: Ahangari, Mohammad, et al.
Publicado: (2023)

Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia
por: Ruderfer, Douglas M., et al.
Publicado: (2013)

Clinical Indicators of Symptom Dimensions and Cognitive Ability in Schizophrenia
por: Farakish, L., et al.
Publicado: (2022)

Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls
por: Shafee, Rebecca, et al.
Publicado: (2018)

Polygenic disruption of retinoid signalling in schizophrenia and a severe cognitive deficit subtype
por: Reay, William R., et al.
Publicado: (2018)

The Relationship Between Polygenic Risk Scores and Cognition in Schizophrenia
por: Richards, Alexander L, et al.
Publicado: (2020)

MiR-137-derived polygenic risk: effects on cognitive performance in patients with schizophrenia and controls
por: Cosgrove, D, et al.
Publicado: (2017)

Joint polygenic and environmental risks for childhood attention‐deficit/hyperactivity disorder (ADHD) and ADHD symptom dimensions
por: Mooney, Michael A., et al.
Publicado: (2023)

Antipsychotic medication-mediated cognitive change in schizophrenia and polygenic score for cognitive ability
por: Blackman, Rachael K., et al.
Publicado: (2021)

Common variants in polygenic schizophrenia
por: Glessner, Joseph T, et al.
Publicado: (2009)

The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia
por: Ang, Mei San, et al.
Publicado: (2017)

Effects of cognitive remediation on negative symptoms dimensions: exploring the role of working memory
por: Cella, M., et al.
Publicado: (2017)

The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study
por: Quattrone, Diego, et al.
Publicado: (2021)

Association between polygenic risk for schizophrenia, neurocognition and social cognition across development
por: Germine, L, et al.
Publicado: (2016)

Influence of polygenic risk scores for schizophrenia and resilience on the cognition of individuals at-risk for psychosis
por: He, Qin, et al.
Publicado: (2021)

Schizophrenia polygenic risk predicts general cognitive deficit but not cognitive decline in healthy older adults
por: Kępińska, Adrianna P., et al.
Publicado: (2020)

Polygenic Risk Scores for Subtyping of Schizophrenia
por: Chen, Jingchun, et al.
Publicado: (2020)

ADHD POLYGENIC RISK AND COGNITIVE PERFORMANCE IN LATER LIFE
por: Mansoor, Marrium, et al.
Publicado: (2022)

Association of Cognitive Polygenic Index and Cognitive Performance with Age in Cognitively Healthy Adults
por: Tsapanou, Angeliki, et al.
Publicado: (2023)

The Relationship Between Cognitive Dysfunction and Symptom Dimensions Across Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
por: Zhu, Yue, et al.
Publicado: (2019)

Sex-specific effects of polygenic risk for schizophrenia on lifespan cognitive functioning in healthy individuals
por: Koch, Elise, et al.
Publicado: (2021)

Dissecting Schizotypy and Its Association With Cognition and Polygenic Risk for Schizophrenia in a Nonclinical Sample
por: Tiego, Jeggan, et al.
Publicado: (2023)

Negative symptom dimensions and social functioning in Chinese patients with schizophrenia
por: Gao, Tianqi, et al.
Publicado: (2022)

Dimensions of manic symptoms in youth: psychosocial impairment and cognitive performance in the IMAGEN sample
por: Stringaris, Argyris, et al.
Publicado: (2014)

Dysfunctional Beliefs and Cognitive Performance across Symptom Dimensions in Childhood and Adolescent OCD
por: Piras, Federica, et al.
Publicado: (2022)

Real-time cognitive performance and positive symptom expression in schizophrenia
por: Dupuy, Maud, et al.
Publicado: (2021)

F74. CLINICAL SYMPTOMS AND NOT OBJECTIVE COGNITIVE PERFORMANCE DRIVE SUBJECTIVE COGNITIVE COMPLAINTS IN PATIENTS WITH SCHIZOPHRENIA
por: Cotter, Jack, et al.
Publicado: (2018)

A Network Analysis of the Association Between Depressive Symptoms and Patient Activation Among Those With Elevated Cardiovascular Risk
por: Lee, Chiyoung, et al.
Publicado: (2022)

Common genetic variation and schizophrenia polygenic risk influence neurocognitive performance in young adulthood
por: Hatzimanolis, Alex, et al.
Publicado: (2015)

S125. THE ROLE OF DUP, DUI AND POLYGENIC SCORE FOR SCHIZOPHRENIA ON COGNITION IN ATHENS FEP STUDY SAMPLE
por: Dimitrakopoulos, Stefanos, et al.
Publicado: (2020)

Association of polygenic risk for schizophrenia with fast sleep spindle density depends on pro-cognitive variants
por: Schilling, Claudia, et al.
Publicado: (2022)

Interactive effects of polygenic risk and cognitive subtype on brain morphology in schizophrenia spectrum and bipolar disorders
por: Quidé, Yann, et al.
Publicado: (2022)

Increased Intrinsic Brain Activity in the Striatum Reflects Symptom Dimensions in Schizophrenia
por: Sorg, Christian, et al.
Publicado: (2013)

F91. ASSOCIATION BETWEEN SYMPTOM DIMENSIONS AND EXECUTIVE FUNCTION IN SCHIZOPHRENIA
por: Franco, Ana Luiza, et al.
Publicado: (2018)

Depressive Symptoms and PANSS Symptom Dimensions in Patients With Predominant Negative Symptom Schizophrenia: A Network Analysis
por: Demyttenaere, Koen, et al.
Publicado: (2022)

27416 DNA Methylation Age Acceleration and Depressive Symptoms in African American Women with Cardiometabolic Conditions
por: Perez, Nicole, et al.
Publicado: (2021)

Polygenic risk for schizophrenia and subcortical brain anatomy in the UK Biobank cohort
por: Grama, Steluta, et al.
Publicado: (2020)

A polygenic score for schizophrenia predicts glycemic control
por: Cao, Han, et al.
Publicado: (2017)

Polygenic contribution to the relationship of loneliness and social isolation with schizophrenia
por: Andreu-Bernabeu, Álvaro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p9v2vc52ul801ffr15oblrm592